Related references
Note: Only part of the references are listed.Consensus guidelines for the use and interpretation of angiogenesis assays
Patrycja Nowak-Sliwinska et al.
ANGIOGENESIS (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy
Pieter-Jan van Dam et al.
SEMINARS IN CANCER BIOLOGY (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Non-angiogenic tumours and their influence on cancer biology
Tom Donnem et al.
NATURE REVIEWS CANCER (2018)
International consensus guidelines for scoring the histopathological growth patterns of liver metastasis
Pieter-Jan van Dam et al.
BRITISH JOURNAL OF CANCER (2017)
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis
Francesco Passiglia et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma
Elizabeth A. Kuczynski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin
Pulathis N. Siriwardana et al.
MEDICINE (2016)
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
Sophia Frentzas et al.
NATURE MEDICINE (2016)
Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases
Nuh N. Rahbari et al.
Science Translational Medicine (2016)
Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma
Elizabeth A. Kuczynski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Imaging of Angiotropism/Vascular Co-Option in a Murine Model of Brain Melanoma: Implications for Melanoma Progression along Extravascular Pathways
Laurent A. Bentolila et al.
SCIENTIFIC REPORTS (2016)
Growth pattern of colorectal liver metastasis as a marker of recurrence risk
R. L. Eefsen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Prognosis according to histochemical analysis of liver metastases removed at liver resection
S. M. Brunner et al.
BRITISH JOURNAL OF SURGERY (2014)
BRAF Mutation Predicts for Poor Outcomes After Metastasectomy in Patients With Metastatic Colorectal Cancer
Rona Yaeger et al.
CANCER (2014)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147
Wilson I. Gonsalves et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
The morphological growth patterns of colorectal liver metastases are prognostic for overall survival
Kare Nielsen et al.
MODERN PATHOLOGY (2014)
RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
Jean-Nicolas Vauthey et al.
ANNALS OF SURGERY (2013)
Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab
F. Loupakis et al.
BRITISH JOURNAL OF CANCER (2013)
Incidence and Prognostic Impact of KRAS and BRAF Mutation in Patients Undergoing Liver Surgery for Colorectal Metastases
Georgios Karagkounis et al.
CANCER (2013)
Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1
Jia Lu et al.
CANCER CELL (2013)
Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab
Christopher G. Smith et al.
CLINICAL CANCER RESEARCH (2013)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger et al.
LANCET ONCOLOGY (2013)
Pilot Study on Pericytic Mimicry and Potential Embryonic/Stem Cell Properties of Angiotropic Melanoma Cells Interacting with the Abluminal Vascular Surface
Claire Lugassy et al.
CANCER MICROENVIRONMENT (2013)
The histological growth pattern of colorectal cancer liver metastases has prognostic value
Gert G. Van den Eynden et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
Bernhard Mlecnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery
L. Rubbia-Brandt et al.
ANNALS OF ONCOLOGY (2007)
Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia
F Stessels et al.
BRITISH JOURNAL OF CANCER (2004)
Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia
PB Vermeulen et al.
JOURNAL OF PATHOLOGY (2001)
Share Paper
